Occupational Health and Safety (Commonwealth Employment) (National Standards) Amendment Regulations 1999 (No. 1) (Cth)

Occupational Health and Safety (Commonwealth Employment) (National Standards) Amendment Regulations 1999 (No. 1)

Statutory Rules 1999 No. 66

I, MAJOR GENERAL MICHAEL JEFFERY, AC, MC, Administrator of the Commonwealth of Australia, acting with the advice of the Federal Executive Council, make the following regulations under theOccupational Health and Safety (Commonwealth Employment) Act 1991.

Dated 30 April 1999.

P.M. JEFFERY

Administrator

By His Excellency’s Command,

PETER REITH

Minister for Employment, Workplace Relations

and Small Business

 

Occupational Health and Safety (Commonwealth Employment) (National Standards) Amendment Regulations 1999 (No. 1)1

Statutory Rules 1999 No. 662

made under the

Occupational Health and Safety (Commonwealth Employment) Act 1991

   

Contents

Page

• •
• •

Do not delete: Part placeholder

Do not delete: Division placeholder

1Name of regulations

 These regulations are the Occupational Health and Safety (Commonwealth Employment) (National Standards) Amendment Regulations 1999 (No. 1).

2Commencement

 These regulations commence on gazettal.

3Amendment of Occupational Health and Safety (Commonwealth Employment) (National Standards) Regulations

 Schedule 1 amends the Occupational Health and Safety (Commonwealth Employment) (National Standards) Regulations.

Schedule 1Amendments

 (regulation 3)

Do not delete: Schedule Part placeholder

[1]Regulation 1.01

substitute

1.01Name of regulations

 These regulations are the Occupational Health and Safety (Commonwealth Employment) (National Standards) Regulations 1994.

[2]Part 6, Division 1, heading

omit

[3]Part 6, Division 1, Subdivision A, heading

substitute

Division 1Introduction

[4]Regulation 6.01, heading

substitute

6.01Objects of Part

[5]Regulation 6.01

omit

 this Division

insert

 this Part

[6]

Note   The boxed Notes after regulation 6.01 should be altered by inserting the following sentence after the second sentence:

The following codes of practice are relevant to the provisions in this Part for scheduled carcinogenic substances and inorganic lead:

 (a) the Approved Code of Practice on the Control and Safe Use of Inorganic Lead in Commonwealth Employment, approved by the Minister on 3 March 1999;

• (b)

  the Approved Code of Practice on the Control of Scheduled Carcinogenic Substances in Commonwealth Employment, approved by the Minister on 3 March 1999.

[7]Regulation 6.02, heading

substitute

6.02Application of Part

[8]Subregulation 6.02 (1)

omit

 this Division

insert

 this Part

[9]Subregulation 6.02 (2)

omit

 This Division

insert

 This Part

[10]Paragraph 6.02 (2) (a)

omit

 applies

[11]Subregulations 6.02 (3) and (4)

omit

 This Division

insert

 This Part

[12]Regulation 6.03, heading

substitute

6.03Definitions for Part

[13]Regulation 6.03

omit

 this Division,

insert

 this Part,

[14]Regulation 6.03, definition of hazardous substance, paragraph (b)

omit

 the “Approved Criteria for Classifying Hazardous Substances [NOHSC:1008 (1994)]”;

insert

 the Approved Criteria for Classifying Hazardous Substances [NOHSC:1008 (1994)]; or

[15]Regulation 6.03, definition of hazardous substance, after paragraph (b)

insert

• (c)

  that is a scheduled carcinogenic substance.

[16]Regulation 6.03

insert

blood-lead levelmeans the concentration of lead in whole blood expressed in micromoles per litre (µmol / L) or micrograms per decilitre ( µg / dL).

bona fide research means a systematic, investigative or experimental activity conducted for the purpose of:

• (a)

  acquiring new knowledge; or

• (b)

  creating new or improved materials, products, devices, processes or services; or

• (c)

  analysis to identify the kind or quantities of ingredients in a substance.

inorganic lead substance means:

• (a)

  lead metal; or

• (b)

  an inorganic lead compound; or

• (c)

  a lead salt of an organic acid.

lead-risk jobmeans a work activity or sequence of work activities in which the blood-lead level of an employee might reasonably be expected to rise, or does rise, above the lower of the following blood lead levels:

• (a)

  1.45 µmol / L (30 µg / dL);

• (b)

  the removal level prescribed in relation to the employee.

removal level has the same meaning as in the Approved Code of Practice on the Control and Safe Use of Inorganic Lead in Commonwealth Employment, as approved by the Minister on 3 March 1999 and as in force on 7 May 1999.

scheduled carcinogenic substance means a substance mentioned in column 2 of Schedule 1A.

[17]Part 6, Division 1, Subdivision B, heading

substitute

Division 2Duties of a manufacturer, and a supplier, of a hazardous substance for the Commonwealth

[18]Paragraph 6.06 (2) (a)

substitute

• (a)

  the supplier supplies the hazardous substance to an employer that is a retailer, or a retail warehouse operator, in a consumer package that holds:

  • (i)

    less than 30 kilograms of the substance; or

  • (ii)

    less than 30 litres of the substance; and

[19]Part 6, Division 1, Subdivision C, heading

substitute

Division 3Duties of an employer in relation to the use of hazardous substances

[20]

Note   The boxed Notes after the heading to Subdivision C should be altered by:

 (a) omitting ‘this Division.’ and inserting ‘this Part.’; and

• (b)

  omitting ‘Subdivision.’ (twice occurring) and inserting ‘Division.’.

[21]Regulation 6.16

omit all the words after

 Schedule 1

insert

 is not handled at work in any circumstance other than a circumstance specified in column 3 of the item.

[22]After regulation 6.16

insert

6.16AExemption from regulation 6.16

• (1)

  Regulation 6.16 does not apply to an employer in relation to a hazardous substance mentioned in Part 2 of Schedule 1 if the Commission exempts the employer from the application of the regulation in relation to the substance.

• (2)

  The Commission may only exempt an employer in accordance with this regulation and regulations 6.16B and 6.16C.

• (3)

  An employer seeking an exemption must:

  • (a)

    apply to the Commission in writing, using the application form (if any) approved by the Commission; and

  • (b)

    include with the application evidence that:

    • (i)

      the use of the hazardous substance is essential to the operation of the employer’s business; and

    • (ii)

      there is no reasonable alternative substance for the hazardous substance.

• (4)

  On receipt of an application, the Commission may, in writing:

  • (a)

    grant the employer the exemption; or

  • (b)

    refuse to grant the exemption; or

  • (c)

    ask the employer to give it further information about the application.

• (5)

  Before granting an employer an exemption, the Commission must be satisfied that:

  • (a)

    the use of the hazardous substance is essential to the operation of the employer’s business; and

  • (b)

    there is no reasonable alternative substance for the hazardous substance; and

  • (c)

    there are no circumstances suggesting that granting the exemption would be inconsistent with the objects of this Part.

• (6)

  If the Commission refuses to grant an exemption, it must give the employer a written notice setting out the reasons for the refusal.

6.16BConditions of an exemption

(1) An exemption granted under regulation 6.16A may be subject to conditions that promote the objects of this Part.

• (2)

  The Commission may, by notice in writing to the holder of an exemption:

  • (a)

    add a condition to the exemption, or vary a condition; or

  • (b)

    revoke a condition.

6.16COperation of an exemption

(1) An exemption granted under regulation 6.16A commences on:

• (a)

  the day on which it is granted; or

• (b)

  a later date stated in the exemption.

• (2)

  The Commission must cancel an exemption if:

  • (a)

    it is satisfied that continuing the exemption would be inconsistent with the objects of this Part; or

  • (b)

    the employer that holds the exemption asks the Commission to cancel it.

• (3)

  The Commission is not required to consult the employer that holds the exemption before cancelling it.

• (4)

  If the Commission cancels an exemption under paragraph (2) (a), it must give the employer a written notice setting out:

  • (a)

    the reasons for cancelling it; and

  • (b)

    the time from which it is cancelled.

• (5)

  An exemption ceases on the earlier of:

  • (a)

    the end of the day (if any) stated in the exemption as the day when it ceases; and

  • (b)

    the time when it is cancelled.

6.16DReview of decision

 Application may be made to the Administrative Appeals Tribunal for review of a decision of the Commission under paragraph 6.16A (4) (b) or 6.16C (2) (a), or subregulation 6.16B (2).

[23]After paragraph 6.17 (2) (a)

insert

• (aa)

  if a job involves the use of an inorganic lead substance — a determination of whether the job is a lead-risk job; and

[24]Paragraph 6.17 (5) (c)

omit

 this Division.

insert

 this Part.

[25]After regulation 6.17

insert

6.17AExposure to scheduled carcinogenic substances

• (1)

  Subregulation (2) applies to an employee if, in the course of the employee’s employment, the employee has been, or the employer reasonably suspects that the employee has been, exposed to a scheduled carcinogenic substance in, or in connection with, a circumstance mentioned in column 3 of Schedule 1A in relation to that substance.

• (2)

  On the termination of the employee’s employment, the employer must provide the employee with a written statement that includes the following information:

  • (a)

    the name of each scheduled carcinogenic substance to which the employee was, or was likely to have been, exposed;

  • (b)

    the period of known exposure to the substance;

  • (c)

    the period of likely exposure to the substance;

  • (d)

    a copy of any relevant assessment report;

  • (e)

    details of how and where the employee can obtain any relevant additional records;

  • (f)

    the advisability of having periodic health assessments and the types of tests that are relevant.

    Penalty:   10 penalty units.

(3) If an employer reasonably suspects that an employee has been accidentally exposed to a scheduled carcinogenic substance, the employer must, as soon as practicable, notify the employee of that exposure.

Penalty:   10 penalty units.

[26]Subregulation 6.20 (1)

omit

 regulation 6.16

insert

 regulation 6.17

[27]Subregulation 6.21 (1)

substitute

• (1)

  An employer must provide health surveillance of an employee who has been identified, during a risk assessment, as being exposed to a hazardous substance if:

  • (a)

    there is a significant risk to the health of the employee from a hazardous substance listed in Schedule 2; or

  • (b)

    the employer believes, or ought reasonably to believe, that:

    • (i)

      the exposure of the employee to the substance has the effect that an identifiable disease or other effect on health may be related to the exposure; and

    • (ii)

      there is a reasonable likelihood that the disease or other effect on health may occur under the particular conditions of work; and

    • (iii)

      there are valid techniques for detecting an indication of the disease or other effect on health; or

  • (c)

    there is a valid biological monitoring procedure available and a reasonable likelihood that accepted values might be exceeded.

    Penalty:   10 penalty units.

[28]Paragraph 6.21 (4) (c)

substitute

• (c)

  if the employee is working in a lead-risk job — on the termination of the employee’s employment, the employee is given access to the results of the health surveillance; and

• (d)

  Comcare is notified of any adverse result detected in health surveillance that is consistent with exposure to the relevant hazardous substance.

[29]After subregulation 6.22 (2)

insert

• (2A)

  If an assessment report, prepared for the purposes of this Part, identifies an employee as likely to have been exposed, in the course of the employee’s employment, to a scheduled carcinogenic substance in, or in connection with, a circumstance mentioned in column 3 of Schedule 1A in relation to that substance, the employer to whom the report relates must:

  • (a)

    keep a record of the full name, date of birth and address of each employee who has been identified as a result of the report; and

  • (b)

    keep the report for at least 30 years from the date of the last entry in the report.

    Penalty:   5 penalty units.

[30]Subregulation 6.22 (4)

substitute

• (4)

  If an employer that keeps a record referred to in subregulation (1), (2) or (2A) ceases operations in the State or Territory in which the record was created, the employer must give the record to Comcare.

  Penalty:   5 penalty units.

[31]Paragraph 6.23 (b)

omit

 Australia

[32]Part 6, Division 1, Subdivision D, heading

substitute

Division 4Employees’ duties in relation to hazardous substances

[33]Part 6, Divisions 2 and 3

omit

[34]Before Schedule 1

insert

Schedule 1A Scheduled carcinogenic substances

 (regulations 6.03, 6.17A and 6.22)

Column 1 Item No	Column 2 Substance name	Column 3 Circumstance
1	2-Acetylaminofluorene	All circumstances
2	Aflatoxins	All circumstances
3	4-Aminodiphenyl	All circumstances
4	Amosite (brown asbestos)	All circumstances other than the following circumstances: (a) removal or disposal of amosite in accordance with a law of a State or Territory relating to the removal of asbestos;
(b) disturbance of naturally occurring amosite that is incidental to operations not related to the extraction or processing of amosite, for example, roadworks
5	Benzidine and its salts, including benzidine dihydrochloride	All circumstances
6	bis(Chloromethyl) ether	All circumstances
7	Chloromethyl methyl ether (technical grade containing bis(chloromethyl) ether)	All circumstances
8	Crocidolite (blue asbestos)	All circumstances other than the following circumstances: (a) removal or disposal of crocidolite in accordance with a law of a State or Territory relating to the removal of asbestos; (b) disturbance of naturally occurring crocidolite that is incidental to operations not related to the extraction or processing of crocidolite, for example, roadworks
9	4-Dimethylaminoazo-benzene	All circumstances
10	2-Naphthylamine and its salts	All circumstances
11	4-Nitrodiphenyl	All circumstances
12	Acrylonitrile	All circumstances
13	Benzene	When contained in a feedstock containing more than 50% of benzene by volume
14	Chrysotile (white asbestos)	When used in the manufacture of asbestos products
15	Cyclophosphamide (cytotoxic drug)	1. When contained in a preparation for therapeutic use in hospitals and oncological treatment facilities. 2. When used in manufacturing operations.
16	3,3´-Dichlorobenzidine and its salts	All circumstances
17	3,3´-Dichlorobenzidine dihydrochloride	All circumstances
18	Diethyl sulfate	All circumstances
19	Dimethyl sulfate	All circumstances
20	Ethylene dibromide	When used as a fumigant
21	4,4´-Methylene bis(2-chloroaniline) — known as ‘MOCA’	All circumstances
22	2-Propiolactone	All circumstances
23	ortho-Toluidine	All circumstances
24	ortho-Toluidine hydrochloride	All circumstances
25	Vinyl chloride monomer	All circumstances

Note   Schedule 1A is not an exhaustive list of carcinogens used in workplaces. The absence of a substance from the Schedule should not be presumed to be indicative of the absence of a carcinogenic hazard. The general requirements of Part 6 apply to all carcinogenic substances that are hazardous substances within the meaning of regulation 6.03.

[35]Schedule 1

substitute

Schedule 1Hazardous substances

 (regulation 6.16)

Part 1Permitted circumstances for handling of certain hazardous substances

Column 1 Item No	Column 2 Substance name	Column 3 Permitted circumstance
101	Polychlorinated biphenyls (also known as PCBs)	1. Handling for storage prior to disposal. 2. Removal or disposal. 3. Use when contained in existing electrical equipment or construction material. 4. Repair of existing electrical equipment or construction material.

Part 2Permitted circumstances for handling of certain hazardous substances with carcinogenic properties

Column 1 Item No	Column 2 Substance name	Column 3 Permitted circumstance
201	2-Acetylaminofluorene	Bona fide research
202	Aflatoxins	Bona fide research
203	4-Aminodiphenyl	Bona fide research
204	Amosite (brown asbestos)	1. Bona fide research. 2. Removal or disposal of amosite in accordance with a law of a State or Territory relating to the removal of asbestos. 3. Disturbance of naturally occurring amosite that is incidental to operations not related to the extraction or processing of amosite, for example, roadworks.
205	Benzidine and its salts, including benzidine dihydrochloride	Bona fide research
206	bis(Chloromethyl) ether	Bona fide research
207	Chloromethyl methyl ether (technical grade containing bis(chloromethyl) ether)	Bona fide research
208	Crocidolite (blue asbestos)	1. Bona fide research. 2. Removal or disposal of crocidolite in accordance with a law of a State or Territory relating to the removal of asbestos. 3. Disturbance of naturally occurring crocidolite that is incidental to operations not related to the extraction or processing of crocidolite, for example, roadworks.
209	4-Dimethylaminoazo-benzene	Bona fide research
210	2-Naphthylamine and its salts	Bona fide research
211	4-Nitrodiphenyl	Bona fide research

[36]Schedule 2, after item 12

insert

13	Benzene	Demography, occupational and medical history and health advice Baseline blood sample for haematological profile Records of personal exposure
14	Creosote	Demography, occupational and medical history Health advice, including recognition of photosensitivity and skin changes Physical examination with emphasis on the neurological system and skin, noting any abnormal lesions and evidence of skin sensitisation Records of personal exposure, including photosensitivity
15	Inorganic chromium	Demography, occupational and medical history and health advice Physical examination with emphasis on the respiratory system and skin Weekly inspection of hands and forearms by the employee’s supervisor
16	Pentachlorophenol	Demography, occupational and medical history and health advice Physical examination with emphasis on the skin, noting any abnormal lesions or effects of irritancy Test for urinary free pentachlorophenal Dipstick urinalysis for haematuria and proteinuria Records of personal exposure

Notes

1. These regulations amend Statutory Rules 1994 No. 414, as amended by 1995 Nos. 53, 98 and 337; 1996 Nos. 129 and 288; 1997 No. 227.

2. Made by the Administrator on 30 April 1999, and notified in the Commonwealth of Australia Gazette